Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Randomized Experiments01:13

Randomized Experiments

9.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.2K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

349
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
349
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

364
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
364
Bias01:22

Bias

7.9K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
7.9K
Crossover Experiments01:16

Crossover Experiments

4.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caveats on Using Firth's Penalization in the Model-Based Regression Standardization for Rare Diseases.

Statistics in medicine·2026
Same author

Effect of home visiting support on maternal psychosocial needs and postnatal depression: emulating a target trial.

BMJ mental health·2026
Same author

Beyond the Hazard Ratio: Causal Inference from Time-to-Event Data with Dependent Censoring, Confounding, and Competing Risks.

Journal of epidemiology·2026
Same author

Prognostic Impact of Renal Function on Outcomes After Physiology-Guided Coronary Revascularization: Insights From the J-PRIDE Registry.

Circulation. Cardiovascular interventions·2026
Same author

Prognostic Implications of Bleeding and Ischemic Complications in Acute Myocardial Infarction-Related Cardiogenic Shock Managed With Microaxial Flow Pump.

Circulation. Cardiovascular interventions·2026
Same author

Doubly robust g-estimation of structural nested cumulative survival time models with non-ignorable, non-monotone missing data in time-varying confounders.

Lifetime data analysis·2026
Same journal

Predictor-Assisted Nonparametric Graphical Models With Multivariate Error-Prone Data.

Statistics in medicine·2026
Same journal

Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.

Statistics in medicine·2026
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 14, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Dynamic Borrowing With a Bias-Tolerance Cap in Augmented Randomized Controlled Trials.

Kota Sawada1, Shogo Nomura2, Tomohiro Shinozaki3,4

  • 1Laboratory of Biostatistics, Department of Data Science, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan.

Statistics in Medicine
|March 12, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical method to address confounding bias when using external control data in clinical trials. The method controls bias within a set tolerance, improving trial efficiency and power.

Keywords:
bias‐tolerance capconfoundingdynamic borrowinghybrid controlinverse probabilityrandomized controlled trial

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.2K
Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

1.3K

Related Experiment Videos

Last Updated: Mar 14, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.2K
Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

1.3K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Epidemiology

Background:

  • Randomized controlled trials (RCTs) are the gold standard but face challenges like cost and duration.
  • External control data offers a solution but is susceptible to confounding bias from unmeasured covariates.
  • Existing methods often fail to adequately address or quantify this confounding bias.

Purpose of the Study:

  • To propose a novel statistical method for estimating confounding effects of unmeasured covariates when using external control data.
  • To develop an estimator that dynamically incorporates external data while adjusting for confounding.
  • To control the expected bias within a prespecified tolerance cap for better stakeholder discussions.

Main Methods:

  • Utilized model-based regression standardization, inverse probability weighting, and augmented inverse probability weighting for continuous/binary outcomes.
  • Developed a dynamic borrowing estimator using a weighted mean, adjusting weights based on estimated confounding.
  • Incorporated a 'bias-tolerance cap' to manage the impact of unmeasured confounding.

Main Results:

  • The proposed method effectively regulated bias within the specified tolerance cap, irrespective of confounding magnitude.
  • Demonstrated significant improvements in statistical power and efficiency when confounding was absent.
  • Successfully applied the method to a real-world case involving advanced pancreatic cancer.

Conclusions:

  • The novel method provides a robust approach to mitigate confounding bias when integrating external control data into RCTs.
  • The bias-tolerance cap facilitates informed decision-making regarding the acceptability of bias in effect estimates.
  • This approach enhances the utility of external data, potentially reducing trial costs and duration while maintaining statistical rigor.